Elicio Therapeutics, Inc. (ELTX)
2.98
-0.06
(-1.97%)
USD |
NASDAQ |
Aug 24, 16:00
2.98
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Market Cap : 65.27M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 65.27M |
| August 21, 2026 | 66.58M |
| August 20, 2026 | 67.35M |
| August 19, 2026 | 68.55M |
| August 18, 2026 | 68.11M |
| August 17, 2026 | 66.14M |
| August 14, 2026 | 67.68M |
| August 13, 2026 | 68.99M |
| August 12, 2026 | 67.02M |
| August 11, 2026 | 66.36M |
| August 10, 2026 | 57.78M |
| August 07, 2026 | 59.46M |
| August 06, 2026 | 58.53M |
| August 05, 2026 | 59.46M |
| August 04, 2026 | 58.90M |
| August 03, 2026 | 53.31M |
| July 31, 2026 | 52.19M |
| July 30, 2026 | 54.24M |
| July 29, 2026 | 53.87M |
| July 28, 2026 | 54.99M |
| July 27, 2026 | 55.92M |
| July 24, 2026 | 55.92M |
| July 23, 2026 | 58.72M |
| July 22, 2026 | 58.16M |
| July 21, 2026 | 57.41M |
| Date | Value |
|---|---|
| July 20, 2026 | 56.67M |
| July 17, 2026 | 57.97M |
| July 16, 2026 | 59.65M |
| July 15, 2026 | 56.67M |
| July 14, 2026 | 57.97M |
| July 13, 2026 | 61.33M |
| July 10, 2026 | 64.87M |
| July 09, 2026 | 65.05M |
| July 08, 2026 | 65.05M |
| July 07, 2026 | 52.19M |
| July 06, 2026 | 61.42M |
| July 02, 2026 | 60.02M |
| July 01, 2026 | 95.81M |
| June 30, 2026 | 72.88M |
| June 29, 2026 | 74.56M |
| June 26, 2026 | 74.56M |
| June 25, 2026 | 69.90M |
| June 24, 2026 | 74.19M |
| June 23, 2026 | 76.61M |
| June 22, 2026 | 77.17M |
| June 18, 2026 | 71.76M |
| June 17, 2026 | 87.79M |
| June 16, 2026 | 51.45M |
| June 15, 2026 | 76.05M |
| June 12, 2026 | 276.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precigen, Inc. | 2.567B |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 239.94B |
| Anika Therapeutics, Inc. | 285.59M |
| BioCryst Pharmaceuticals, Inc. | 2.471B |
Market Cap Related Metrics
| Price to Book Value | 8.223 |
| Price | 2.98 |
| Earnings Yield | -70.93% |